Dilafor is in the process of identifying strategic partners interested in developing and commercializing tafoxiparin globally or regionally.

Please contact:
Lena Degling Wikingsson, CEO
+46707900207
Lena.wikingsson@dilafor.com

As many as 40% of all pregnant women experience protracted labor, which carries a high risk of complications for both mothers and infants.